These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32952830)

  • 1. Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage.
    Zgaya R; Ghadhab I; Triki MA; Briki R
    Pan Afr Med J; 2020; 36():186. PubMed ID: 32952830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
    Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
    PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.
    Ugwu IA; Oluwasola TA; Enabor OO; Anayochukwu-Ugwu NN; Adeyemi AB; Olayemi OO
    Int J Gynaecol Obstet; 2016 May; 133(2):173-7. PubMed ID: 26892695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
    Zuberi NF; Durocher J; Sikander R; Baber N; Blum J; Walraven G
    BMC Pregnancy Childbirth; 2008 Aug; 8():40. PubMed ID: 18718007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P; Biswas J; Mandal A
    Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised placebo controlled trial of oral misoprostol in the third stage of labour.
    Hofmeyr GJ; Nikodem VC; de Jager M; Gelbart BR
    Br J Obstet Gynaecol; 1998 Sep; 105(9):971-5. PubMed ID: 9763047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.
    Tewatia R; Rani S; Srivastav U; Makhija B
    Arch Gynecol Obstet; 2014 Apr; 289(4):739-42. PubMed ID: 24045979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
    Chaudhuri P; Majumdar A
    Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage.
    Priya GP; Veena P; Chaturvedula L; Subitha L
    Arch Gynecol Obstet; 2015 Dec; 292(6):1231-7. PubMed ID: 25990482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage.
    Shrestha A; Dongol A; Chawla CD; Adhikari RK
    Kathmandu Univ Med J (KUMJ); 2011; 9(33):8-12. PubMed ID: 22610801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
    Chaudhuri P; Majumdar A
    Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized, placebo-controlled trial of misoprostol and routine uterotonics for the prevention of postpartum hemorrhage.
    Fawole AO; Sotiloye OS; Hunyinbo KI; Umezulike AC; Okunlola MA; Adekanle DA; Osamor J; Adeyanju O; Olowookere OO; Adekunle AO; Singata M; Mangesi L; Hofmeyr GJ
    Int J Gynaecol Obstet; 2011 Feb; 112(2):107-11. PubMed ID: 21130446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benefit of misoprostol for prevention of postpartum hemorrhage in cesarean section: a randomized controlled trial].
    Fekih M; Jnifene A; Fathallah K; Ben Regaya L; Memmi A; Bouguizene S; Chaieb A; Bibi M; Khairi H
    J Gynecol Obstet Biol Reprod (Paris); 2009 Nov; 38(7):588-93. PubMed ID: 19833454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis.
    Parry Smith WR; Papadopoulou A; Thomas E; Tobias A; Price MJ; Meher S; Alfirevic Z; Weeks AD; Hofmeyr GJ; Gülmezoglu AM; Widmer M; Oladapo OT; Vogel JP; Althabe F; Coomarasamy A; Gallos ID
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012754. PubMed ID: 33232518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study.
    Elgafor el Sharkwy IA
    Arch Gynecol Obstet; 2013 Dec; 288(6):1231-6. PubMed ID: 23689739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
    Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage: A Randomized Controlled Trial.
    Quibel T; Ghout I; Goffinet F; Salomon LJ; Fort J; Javoise S; Bussieres L; Aegerter P; Rozenberg P;
    Obstet Gynecol; 2016 Oct; 128(4):805-11. PubMed ID: 27607864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
    Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
    Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital.
    Musa AO; Ijaiya MA; Saidu R; Aboyeji AP; Jimoh AA; Adesina KT; Abdul IF
    Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour.
    Walley RL; Wilson JB; Crane JM; Matthews K; Sawyer E; Hutchens D
    BJOG; 2000 Sep; 107(9):1111-5. PubMed ID: 11002954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.